SD
Shylaja Dharmegowda Sabbanahalli
About Shylaja Dharmegowda Sabbanahalli
Data last updated:
Shylaja Dharmegowda Sabbanahalli is a Director at Meclon Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Meclon Pharmaceuticals Private Limited reported revenue of ₹1.49 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Meclon Pharmaceuticals Private Limited U24230KA2016PTC085079 | Director | 27 Apr 2021 | 2016 | ₹1.49 Cr (FY 2023) | Active |
Board colleagues of Shylaja Dharmegowda Sabbanahalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dharme Gowda Nidhi | 09202830 | Meclon Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shylaja Dharmegowda Sabbanahalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shylaja Dharmegowda Sabbanahalli
Shylaja Dharmegowda Sabbanahalli currently holds 1 directorship: Meclon Pharmaceuticals Private Limited (Director, since 27 Apr 2021, revenue ₹1.49 Cr (FY 2023)).
Shylaja Dharmegowda Sabbanahalli was first appointed on 27 Apr 2021 as Director at Meclon Pharmaceuticals Private Limited.
The current boards of Shylaja Dharmegowda Sabbanahalli's companies include Dharme Gowda Nidhi (Meclon Pharmaceuticals Private Limited).